Merck
Worldwide
   
En español

 



About this Study
Condition Intervention Phase
Human Immunodeficiency Virus Drug: MK-0518
BENCHMRK ExPI
More about
 
You may be eligible for the study if you:

AGES: 18 years and older
GENDER: male and female

Inclusion Criteria:

  • Are HIV positive with a viral load <50 copies/mL
  • Are currently receiving HIV treatment that includes a protease inhibitor
  • Are not currently on any lipid lowering treatment

Participation in this 1-year study includes regular doctor visits, the investigational study drug or standard of care HIV medication, and laboratory testing.

Copyright © 2005-2007 Merck & Co., Inc., All rights reserved.

Contact Merck Privacy Policy Terms of Use Copyright Merck & CO., Inc. (USA)